Patients Stopping Slimming Medications Regain Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

Fresh analysis indicates that patients who discontinue new slimming jabs like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who end conventional diet and exercise regimens.

Research printed in a leading medical journal points out that while overweight individuals often shed a large proportion of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month once they quit.

"Users buying such drugs should be aware of the risk of quick weight regain when the treatment concludes," warns expert Dr. Susan Jebb.

Such speed of regain suggests a reversion to original weight within about one and a half years.

Analyzing Approaches

The study, which looked at dozens of studies involving over 9,000 of participants, contrasted the effects of the injectable medications with other pills.

Researchers note that people who lose weight through diet and exercise typically see a more gradual weight regain—perhaps 0.1 kg a month—after stopping.

The Reason for the Quick Regain

Doctors believe the mode of action of the drugs is key to understanding the amplified rebound.

These medications imitate a natural hormone called GLP-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this hormone supplement means hunger is no longer kept in check, making binge eating far more likely."

A Lifelong Condition?

Health authorities suggest the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals argue that, due to the significant potential of relapse, the therapy should be considered ongoing.

This view is reinforced by drug manufacturers, who note that the findings "highlight the persistent nature of excess weight," comparing it to managing conditions like diabetes.

Patient Experiences

Users who have discontinued the jabs explain a powerful resurgence of hunger.

"It was like something activating and you're instantly starving," described an individual.

The struggle is compounded if patients have not adopted lasting lifestyle or habit modifications during therapy.

Widespread Adoption

Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.

• Adoption is more common among females than men.
• The 40s and 50s demographic shows the highest level of interest.
• Many obtain the medications through private prescriptions rather than public health services.

In conclusion, researchers emphasize that while these medications are powerful agents for weight loss, they are not a magic cure and long-term success hinges on integrated behavioural management.